Clinical Trials Browser

Phase 1 × GSK 1363089 × Gastrointestinal × Clear all

NCT00920192 2017-07-18

Safety Study of Foretinib (GSK1363089) in Adults With Liver Cancer

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular